摘要
目的探索胰岛素泵入与皮下注射胰岛素治疗初发2型糖尿病的临床疗效。方法本次研究选取2016年4月至2018年5月在我院治疗初发2型糖尿病回顾性分析了87例患者。初发2型糖尿病患者被归类为胰岛素泵入组(实验组):44例患者采用胰岛素泵入方案治疗;皮下注射胰岛素组(对照组):43例患者采取皮下注射胰岛素方案治疗。比较两组患者的临床疗效以及血酮体转阴时间、血糖达标时间、低血糖发生频率及胰岛素用量等指标。结果①经过治疗发现胰岛素泵入组患者总有效率对比皮下注射胰岛素组具有明显优势P<0.05。②经过治疗发现胰岛素泵入组患者血酮体转阴时间、血糖达标时间、低血糖发生频率及胰岛素用量等指标对比皮下注射胰岛素组具有明显优势P<0.05。结论采用胰岛素泵入治疗初发2型糖尿病效果确切,对比临床疗效、患者血酮体转阴时间、血糖达标时间、低血糖发生频率及胰岛素用量等指标等方面有明显的优势。
Objective To explore the clinical efficacy of insulin pumping and subcutaneous injection of insulin for the treatment of primary type 2 diabetes mellitus. Methods From April 2016 to May 2018, 87 patients with primary type 2 diabetes mellitus were retrospectively analyzed in our hospital. Patients with primary type 2 diabetes mellitus were classified as Insulin Pump Group(experimental group): 44 patients were treated with insulin pumping scheme. Subcutaneous Injection Insulin Group(control group): 43 patients were treated with subcutaneous injection insulin. The clinical efficacy, blood ketone body turning time, blood glucose standard time, hypoglycemia frequency and insulin dosage were compared. Results ①After the treatment, the total efficiency of insulin pump group patients had obvious advantages when compared with subcutaneous insulin group(P<0.05). ②After the treatment, the blood ketone turning time, blood glucose standard time, low blood glucose frequency and insulin dosage insulin pump group had significant advantages when compared with subcutaneous insulin group(P<0.05). Conclusion For the treatment of primary type 2 diabetes mellitus, the effect of insulin pumping is accurate, which has obvious advantages in clinical curative effect, blood ketone turning time, blood glucose standard time, low blood glucose occurrence frequency and insulin dosage.
作者
周闯
ZHOU Chuang(The Fifth Endocrine Department,Haicheng Central Hospital,Haicheng 114200,China)
出处
《中国医药指南》
2020年第21期79-80,共2页
Guide of China Medicine
关键词
胰岛素泵入
皮下注射胰岛素
初发2型糖尿病
临床疗效
Insulin pump
Subcutaneous injection of insulin
Primary type 2 diabetes mellitus
Clinical efficacy
